SEC Form 4 · accession 0000899243-15-006598
Spark Therapeutics, Inc. · ONCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen W Webster
Officer — Chief Financial Officer
Period of report
Oct 7, 2015
Accepted (ET)
Oct 9, 2015 · 7:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 7, 2015 | M | 20,000 | $3.45 | A | 22,500 | D | |
| Common Stock | Oct 7, 2015 | S | 20,000 | $48.86 | D | 2,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.45 | Oct 7, 2015 | M | 20,000 | D | — | Jul 7, 2024 | Common Stock | 20,000 | 166,015 | D |
Explanation of responses
- F1This option was granted on July 7, 2014 and vests over four years, with 25% of the shares underlying the option vesting on July 7, 2015, and the remainder vesting quarterly thereafter.